Detailed examination of lymph nodes improves prognostication in colorectal cancer

International Journal of Cancer

Volumn 126, Issue 11, 2010, Pages 2644-2652

  Doekhie, Fania S ^a,b   Mesker, Wilma E ^a   Kuppen, Peter J ^a   Van Leeuwen, Gijs A ^c   Morreau, Hans ^a   De Bock, Geertruida H ^d   Putter, Hein ^a   Tanke, Hans J ^a   Van De Velde, Cornelis J ^a   Tollenaar, Rob A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Flevo Hospital   (Netherlands)

^c RIJNLAND HOSPITAL   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Colorectal cancer; Immunohistochemistry; Isolated tumor cells; Lymph nodes; Micrometastases; Multilevel sectioning

Indexed keywords

CYTOKERATIN;

AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MICROSCOPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR CELL; CANCER STAGING; CLASSIFICATION; COLORECTAL TUMOR; CONFIDENCE INTERVAL; LYMPH NODE; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE;

AGED; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 77951250766     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24817     Document Type: Article

References (45)

1. Cianchi F, Palomba A, Boddi V, Messerini L, Pucciani F, Perigli G, Bechi P, Cortesini C. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg 2002;26:384-389 (Pubitemid 36920420)
2. Shida H, Ban K, Matsumoto M, Masuda K, Imanari T, Machida T, Yamamoto T. Prognostic significance of location of lymph node metastases in colorectal cancer. Dis Colon Rectum 1992;35:1046-1050
3. Greene FL, Stewart AK, Norton HJ. A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Ann Surg 2002;236:416-421
4. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC, Glick JH. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-358 (Pubitemid 20042739)
5. Impact B2 Investigators.Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. J Clin Oncol 1999;17:1356-1363
6. Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ;Quasar Collaborative Group.Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 2007;370: 2020-2029
7. Madbouly KM, Senagore AJ, Mukerjee A, Delaney CP, Connor J, Fazio VW. Does immunostaining effectively upstage colorectal cancer by identifying micrometastatic nodal disease? Int J Colorectal Dis 2007;22:39-48.
8. Petersen VC, Baxter KJ, Love SB, Shepherd NA. Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer. Gut 2002;51:65-69
9. http://www.nci.nih.gov/cancertopics/pdq/treatment/colon/ HealthProfessional/page8. 2008.
10. Hermanek P, Hutter RV, Sobin LH, Wittekind C. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 1999;86: 2668-2673
11. Sobin LH, Wittekind C.UICC TNM classification of malignant tumours, 6th edn.New York:Wiley,2002.
12. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M.AJCC cancer staging manual, 6th edn.New York:Springer-Verlag,2002.
13. Doekhie FS, Kuppen PJ, Peeters KC, Mesker WE, Soest R, Morreau H, Velde van de CJ, Tanke HJ, Tollenaar RA. Prognostic relevance of occult tumour cells in lymph nodes in colorectal cancer. Eur J Surg Oncol 2006;32:253-258
14. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ, Tollenaar RA. Micrometastases and survival in stage II colorectal cancer [see comments]. N Engl J Med 1998;339:223-228 (Pubitemid 28350164)
15. Dowlatshahi K, Fan M, Anderson JM, Bloom KJ. Occult metastases in sentinel nodes of 200 patients with operable breast cancer. Ann Surg Oncol 2001;8:675-681 (Pubitemid 32847934)
16. Mesker WE, Doekhie FS, Vrolijk H, Keyzer R, Sloos WCR, Morreau H, O'Kelly PS, de Bock GH, Tollenaar RAEM, Tanke HJ. Automated analysis of multiple sections for the detection of occult cells in lymph nodes. Clin Cancer Res 2003;9:4826-4834 (Pubitemid 37323286)
17. Doekhie FS, Mesker WE, Krieken JH, Kok NF, Hartgrink HH, Kranenbarg EK, Putter H, Kuppen PJ, Tanke HJ, Tollenaar RA, Velde CJ. Clinical relevance of occult tumor cells in lymph nodes from gastric cancer patients. Am J Surg Pathol 2005;29: 1135-1144 (Pubitemid 41232984)
18. Mori M, Mimori K, Ueo H, Tsuji K, Shiraishi T, Barnard GF, Sugimachi K, Akiyoshi T. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol 1998;16: 128-132 (Pubitemid 28041589)
19. Cagir B, Gelmann A, Park J, Fava T, Tankelevitch A, Bittner EW, Weaver EJ, Palazzo JP, Weinberg D, Fry RD, Waldman SA. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer. Ann Intern Med 1999;131:805-812
20. Rosenberg R, Hoos A, Mueller J, Baier P, Stricker D, Werner M, Nekarda H, Siewert JR. Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J Clin Oncol 2002;20:1049-1055 (Pubitemid 34144594)
21. Noura S, Yamamoto H, Ohnishi T, Masuda N, Matsumoto T, Takayama O, Fukunaga H, Miyake Y, Ikenaga M, Ikeda M, Sekimoto M, Matsuura N, et al. Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. J Clin Oncol 2002;20:4232-4241 (Pubitemid 35191026)
22. Merrie AEH, van Rij AM, Dennett ER, Phillips LV, Yun K, McCall JL. Prognostic significance of occult metastases in colon cancer. Dis Colon Rectum 2003;46:221-231 (Pubitemid 36222621)
23. Mesker WE, Vrolijk H, Sloos WC, Tollenaar RA, Tanke HJ. Detection of tumor cells in bone marrow, peripheral blood and lymph nodes by automated imaging devices. Cell Oncol 2006;28: 141-150 (Pubitemid 44427397)
24. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 2007; 99:433-441 (Pubitemid 47073566)
25. Iddings D, Ahmad A, Elashoff D, Bilchik A. The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis. Ann Surg Oncol 2006;13:1386-1392
26. Chen J, Byrne GE, Jr, Lossos IS. Optimization of RNA extraction from formalin-fixed, paraffin-embedded lymphoid tissues. Diagn Mol Pathol 2007; 16:61-72. (Pubitemid 47164737)
27. Gloghini A, Canal B, Klein U, Dal Maso L, Perin T, Dalla-Favera R, Carbone A. RT-PCR analysis of RNA extracted from Bouin-fixed and paraffin-embedded lymphoid tissues. J Mol Diagn 2004;6: 290-296 (Pubitemid 39517396)
28. Nordgard O, Oltedal S, Korner H, Aasprong OG, Tjensvoll K, Gilje B, Heikkila R. Quantitative RT-PCR detection of tumor cells in sentinel lymph nodes isolated from colon cancer patients with an ex vivo approach. Ann Surg 2009;249: 602-607
29. Bilchik AJ, Nora DT, Sobin LH, Turner RR, Trocha S, Krasne D, Morton DL. Effect of lymphatic mapping on the new tumor-node-metastasis classification for colorectal cancer. J Clin Oncol 2003;21: 668-672 (Pubitemid 46621901)
30. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 1994;73: 563-569 (Pubitemid 24046594)
31. Sasaki M, Watanabe H, Jass JR, Ajioka Y, Kobayashi M, Matsuda K, Hatakeyama K. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in "node-negative" colorectal cancer. J Gastroenterol 1997;32: 758-764
32. Isaka N, Nozue M, Doy M, Fukao K. Prognostic significance of perirectal lymph node micrometastases in Dukes' B rectal carcinoma: an immunohistochemical study by CAM5.2. Clin Cancer Res 1999;5: 2065-2068 (Pubitemid 29399259)
33. Clarke G, Ryan E, O'Keane JC, Crowe J, MacMathuna P. The detection of cytokeratins in lymph nodes of Duke's B colorectal cancer subjects predicts a poor outcome. Eur J Gastroenterol Hepatol 2000; 12:549-552 (Pubitemid 30326622)
34. Yasuda K, Adachi Y, Shiraishi N, Yamaguchi K, Hirabayashi Y, Kitano S. Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol 2001;8:300-304 (Pubitemid 32422854)
35. Shimoyama M, Yamazaki T, Suda T, Hatakeyama K. Prognostic significance of lateral lymph node micrometastases in lower rectal cancer - an immunohistochemical study with CAM5.2. Dis Colon Rectum 2003;46:333-339 (Pubitemid 36331651)
36. Bukholm IR, Bondi J, Wiik P, Nesland JM, Andersen SN, Bakka A, Bukholm G. Presence of isolated tumour cells in mesenteric lymph nodes predicts poor prognosis in patients with stage II colon cancer. Eur J Surg Oncol 2003;29:862-866 (Pubitemid 37493285)
37. Rosenberg R, Friederichs J, Gertler R, Hoos A, Mueller J, Nahrig J, Nekarda H, Siewert JR. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer. Int J Colorectal Dis 2004; 19:430-437 (Pubitemid 39193808)
38. Messerini L, Cianchi F, Cortesini C, Comin CE. Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma. Hum Pathol 2006;37:1259-1267 (Pubitemid 44380278)
39. Johnson PM, Malatjalian D, Porter GA. Adequacy of nodal harvest in colorectal cancer: a consecutive cohort study. J Gastrointest Surg 2002;6:883-888 (Pubitemid 40433476)
40. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: a population-based study. J. Natl Cancer Inst 2005;97:219-225 (Pubitemid 40277372)
41. Ostadi MA, Harnish JL, Stegienko S, Urbach DR. Factors affecting the number of lymph nodes retrieved in colorectal cancer specimens. Surg Endosc 2007;21: 2142-2146 (Pubitemid 350125964)
42. Pusztaszeri M, Matter M, Kuonen A, Bouzourene H. Nodal staging in colorectal cancer: should distant lymph nodes be recovered in surgical specimens? Hum Pathol 2009;40:552-557
43. Haboubi NY, Abdalla SA, Amini S, Clark P, Dougal M, Dube A, Schofield P. The novel combination of fat clearance and immunohistochemistry improves prediction of the outcome of patients with colorectal carcinomas: a preliminary study. Int J Colorectal Dis 1998;13:99-102. (Pubitemid 28239683)
44. Scott KW, Grace RH, Gibbons P. Five-year follow-up study of the fat clearance technique in colorectal carcinoma. Dis Colon Rectum 1994;37: 126-128 (Pubitemid 24083061)
45. Bilchik AJ, Hoon DS, Saha S, Turner RR, Wiese D, DiNome M, Koyanagi K, McCarter M, Shen P, Iddings D, Chen SL, Gonzalez M, et al. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. Ann Surg 2007;246: 568-575 (Pubitemid 47480600)